In this regard, we speculate that FG-4592 pretreatment may be a powerful strategy to prevent the activation of HIF-1α induced by constant hypoxia during the recovery phase of AKI, thereby promoting tubular repair and improving its prognosis. This evidence concerns the gene HIF1A and acute kidney injury.